Daeiou Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Pondicherry, Pondicherry, India, established in 2009.
2009 Pondicherry, Pondicherry, India Active
Last Updated:
Access Report
About Daeiou Pharmaceuticals Private Limited

Daeiou Pharmaceuticals Private Limited, a active private limited company, was established on 21 October 2009 in Pondicherry, Pondicherry, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232PY2009PTC002373. Registered under ROC Roc Pondicherry. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹11.71 Cr.

It upholds a compliant status. Employing 32 professional, Its leadership includes Chitrah Rangasamy (Director), Nalliyappan Shanmugapriya (Director), Aruljothi Srinivasan (Director). Past directors included Raghunaathan Ramaswamy, Raghuraman Parthasarathy, Chitrah Rangasamy. It holds ₹7.25 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 19Th Cross Street, Plot No. B-144 & B-153, Pipdic Industrial Estate, Pondicherry, Pondicherry, 605009.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232PY2009PTC002373

  • Registration Number

    002373

  • Incorporation Date

    21 October 2009

  • Authorized Capital

    ₹20.00 Cr

  • Paid-Up Capital

    ₹11.71 Cr

  • ROC Code

    Roc Pondicherry

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 20.00 Cr
  • Paid Up Capital ₹ 11.71 Cr
  • Company Age 16 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 7.25 Cr
  • Revenue Growth **** 2.59%
  • Profit Growth **** -7804.73%
  • Ebitda **** -511.88%
  • Net Worth 47.50%
  • Total Assets **** 42.96%
Company report

Daeiou Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Daeiou Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Daeiou Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Chitrah Rangasamy Director 10 Mar 2025 Current
Nalliyappan Shanmugapriya Director 06 Jul 2023 Current
Aruljothi Srinivasan Director 20 Apr 2019 Current
Elamurugaraja Muthusamy Director 20 Apr 2019 Current
Sengottuvel Director 10 Mar 2025 Current
Vivekanandan Sumathi Director 19 Mar 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Apr 2019 Past
Pramod Abcsdd Director 03 Oct 2024 Past
Pramod Abcsdd Additional Director 29 Sep 2025 Past
Pramod Abcsdd Director 01 Nov 2010 Past
Pramod Abcsdd Director 20 May 2019 Past
Pramod Abcsdd Director 05 Mar 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Daeiou Pharmaceuticals.

Daeiou Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.59% increase. The company also saw a substantial fall in profitability, with a 7804.73% decrease in profit. The company's net worth Soared by an impressive increase of 47.5%.

Daeiou Pharmaceuticals revenue growth over time
Daeiou Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 2.59%
*******
*******
*******
*******
Revenue from Operations
*******
 2.59%
*******
*******
*******
*******
Total Assets
*******
 42.96%
*******
*******
*******
*******
Profit or Loss
*******
 -7804.73%
*******
*******
*******
*******
Net Worth
*******
 47.50%
*******
*******
*******
*******
EBITDA
*******
 -511.88%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Daeiou Pharmaceuticals?

In 2023, Daeiou Pharmaceuticals had a promoter holding of 27.74% and a public holding of 72.26%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹72,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 6.85 Cr
  • Indian Overseas Bank : 0.40 Cr
Latest Charge Details
Date Lender Amount Status
20 Aug 2024 Others ₹3.35 Cr Open
20 Aug 2024 Others ₹3.50 Cr Open
21 Aug 2012 Indian Overseas Bank ₹4.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Daeiou Pharmaceuticals?

Daeiou Pharmaceuticals has a workforce of 32 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Daeiou Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daeiou Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Daeiou Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Palanichamy Vinoth Kumar was appointed as a Ceo was appointed as a Ceo on 26 Dec 2025 & has been associated with this company since 2 months 5 days . was recorded as a recent event.

  • Director Appointment

    The activity Jayanthi Ravi Madhuritha was appointed as a Additional Director was appointed as a Additional Director on 06 Oct 2025 & has been associated with this company since 4 months 25 days . was completed.

  • Director Appointment

    Progress on Manisha Singh was appointed as a Company Secretary was appointed as a Company Secretary on 30 Apr 2025 & has been associated with this company since 10 months . was documented.

  • Director Appointment

    Progress on Chitrah Rangasamy was appointed as a Director was appointed as a Director on 10 Mar 2025 & has been associated with this company since 11 months 21 days . was documented.

  • Director Appointment

    Sengottuvel was appointed as a Director was appointed as a Director on 10 Mar 2025 & has been associated with this company since 11 months 21 days . was recorded as a recent event.

  • Annual General Meeting

    The activity Daeiou Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Daeiou Pharmaceuticals Private Limited?

The CIN of Daeiou Pharmaceuticals Private Limited is U24232PY2009PTC002373.

Where is Daeiou Pharmaceuticals Private Limited headquartered?

Daeiou Pharmaceuticals Private Limited is headquartered at 19Th Cross Street, Plot No. B-144 & B-153, Pipdic Industrial Estate, Pondicherry, Pondicherry, 605009.

When was Daeiou Pharmaceuticals Private Limited incorporated?

Daeiou Pharmaceuticals Private Limited was incorporated on 21 October 2009.

Who are the current directors of Daeiou Pharmaceuticals Private Limited?

The current directors of Daeiou Pharmaceuticals Private Limited are

What is the primary industry of Daeiou Pharmaceuticals Private Limited?

The primary industry of Daeiou Pharmaceuticals Private Limited is Manufacturing.

Is Daeiou Pharmaceuticals Private Limited a listed company?

Daeiou Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Daeiou Pharmaceuticals Private Limited?

The authorized capital of Daeiou Pharmaceuticals Private Limited is ₹20.00 Cr, and the paid-up capital is ₹11.71 Cr.

What is the compliance status of Daeiou Pharmaceuticals Private Limited?

The compliance status of Daeiou Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available